NCT03479671View on ClinicalTrials.gov

Low Dose Fat-Induced Insulin Resistance

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Diabetes Mellitus, Type 2Insulin ResistanceInsulin Sensitivity
Interventions
DRUG

Intralipid, 20% Intravenous Emulsion

Fatty Acid Infusion, either in low-dose (30 ml/hr) or medium-dose (60 ml/hr)

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER